Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Joint synthesis of conditionally related multiple outcomes makes better use of data than separate meta-analyses.

Anwer S, Ades AE, Dias S.

Res Synth Methods. 2019 Nov 4. doi: 10.1002/jrsm.1380. [Epub ahead of print]

PMID:
31680481
2.

Quantifying how diagnostic test accuracy depends on threshold in a meta-analysis.

Jones HE, Gatsonsis CA, Trikalinos TA, Welton NJ, Ades AE.

Stat Med. 2019 Oct 30;38(24):4789-4803. doi: 10.1002/sim.8301. Epub 2019 Sep 30.

4.

Population Adjustment Methods for Indirect Comparisons: A Review of National Institute for Health and Care Excellence Technology Appraisals.

Phillippo DM, Dias S, Elsada A, Ades AE, Welton NJ.

Int J Technol Assess Health Care. 2019 Jan;35(3):221-228. doi: 10.1017/S0266462319000333. Epub 2019 Jun 13.

5.

Correction: Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections.

Blomquist PB, Migchelsen SJ, Wills G, McClure E, Ades AE, Kounali D, Dunbar JK, McClure MO, Soldan K, Woodhall SC, Horner P.

PLoS One. 2019 Apr 24;14(4):e0216193. doi: 10.1371/journal.pone.0216193. eCollection 2019.

6.

Threshold Analysis as an Alternative to GRADE for Assessing Confidence in Guideline Recommendations Based on Network Meta-analyses.

Phillippo DM, Dias S, Welton NJ, Caldwell DM, Taske N, Ades AE.

Ann Intern Med. 2019 Apr 16;170(8):538-546. doi: 10.7326/M18-3542. Epub 2019 Mar 26.

7.

Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys.

Kounali DZ, Welton NJ, Soldan K, Woodhall SC, Dunbar JK, Migchelsen SJ, Mercer CH, Horner P, Ades AE.

Epidemiol Infect. 2019 Jan;147:e107. doi: 10.1017/S0950268819000347.

8.

Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections.

Blomquist PB, Mighelsen SJ, Wills G, McClure E, Ades AE, Kounali D, Dunbar JK, McClure MO, Soldan K, Woodhall SC, Horner P.

PLoS One. 2018 Dec 17;13(12):e0208652. doi: 10.1371/journal.pone.0208652. eCollection 2018. Erratum in: PLoS One. 2019 Apr 24;14(4):e0216193.

9.

Sensitivity of treatment recommendations to bias in network meta-analysis.

Phillippo DM, Dias S, Ades AE, Didelez V, Welton NJ.

J R Stat Soc Ser A Stat Soc. 2018 Jun;181(3):843-867. doi: 10.1111/rssa.12341. Epub 2017 Dec 6.

10.

Use of a random effects meta-analysis in the design and analysis of a new clinical trial.

Jones HE, Ades AE, Sutton AJ, Welton NJ.

Stat Med. 2018 Dec 30;37(30):4665-4679. doi: 10.1002/sim.7948. Epub 2018 Sep 6.

11.

Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal.

Phillippo DM, Ades AE, Dias S, Palmer S, Abrams KR, Welton NJ.

Med Decis Making. 2018 Feb;38(2):200-211. doi: 10.1177/0272989X17725740. Epub 2017 Aug 19.

12.

Proportion of Tubal Factor Infertility due to Chlamydia: Finite Mixture Modeling of Serum Antibody Titers.

Ades AE, Price MJ, Kounali D, Akande VA, Wills GS, McClure MO, Muir P, Horner PJ.

Am J Epidemiol. 2017 Jan 15;185(2):124-134. doi: 10.1093/aje/kww117. Epub 2017 Jan 6.

PMID:
28062393
13.

Evidence Synthesis of Treatment Efficacy in Decision Making: A Reviewer's Checklist [Internet].

Ades AE, Caldwell DM, Reken S, Welton NJ, Sutton AJ, Dias S.

London: National Institute for Health and Care Excellence (NICE); 2012 Jan.

14.

Embedding Evidence Synthesis in Probabilistic Cost-Effectiveness Analysis: Software Choices [Internet].

Dias S, Sutton AJ, Welton NJ, Ades AE.

London: National Institute for Health and Care Excellence (NICE); 2012 Apr.

15.

Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment [Internet].

Dias S, Sutton AJ, Welton NJ, Ades AE.

London: National Institute for Health and Care Excellence (NICE); 2012 Apr.

16.

Introduction to Evidence Synthesis for Decision Making [Internet].

Dias S, Welton NJ, Sutton AJ, Ades AE.

London: National Institute for Health and Care Excellence (NICE); 2012 Apr.

17.

Risk of reproductive complications following chlamydia testing.

Price MJ, Horner PJ, Ades AE.

Lancet Infect Dis. 2016 Nov;16(11):1223-1224. doi: 10.1016/S1473-3099(16)30379-6. No abstract available.

PMID:
27788979
18.

Extrapolation of Survival Curves from Cancer Trials Using External Information.

Guyot P, Ades AE, Beasley M, Lueza B, Pignon JP, Welton NJ.

Med Decis Making. 2017 May;37(4):353-366. doi: 10.1177/0272989X16670604. Epub 2016 Sep 29.

19.

Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England.

Price MJ, Ades AE, Welton NJ, Simms I, Horner PJ.

Epidemiol Infect. 2017 Jan;145(1):208-215. Epub 2016 Sep 28.

PMID:
27678278
20.

Evidence Synthesis in the Baseline Natural History Model [Internet].

Dias S, Welton NJ, Sutton AJ, Ades AE.

London: National Institute for Health and Care Excellence (NICE); 2012 Apr.

21.
22.

NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials [Internet].

Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE.

London: National Institute for Health and Care Excellence (NICE); 2014 Apr.

23.

A threshold analysis assessed the credibility of conclusions from network meta-analysis.

Caldwell DM, Ades AE, Dias S, Watkins S, Li T, Taske N, Naidoo B, Welton NJ.

J Clin Epidemiol. 2016 Dec;80:68-76. doi: 10.1016/j.jclinepi.2016.07.003. Epub 2016 Jul 16.

24.

Proportion of Pelvic Inflammatory Disease Cases Caused by Chlamydia trachomatis: Consistent Picture From Different Methods.

Price MJ, Ades AE, Welton NJ, Simms I, Macleod J, Horner PJ.

J Infect Dis. 2016 Aug 15;214(4):617-24. doi: 10.1093/infdis/jiw178. Epub 2016 Jun 3.

25.

Classes of antihypertensive agents and mortality in hypertensive patients with type 2 diabetes-Network meta-analysis of randomized trials.

Remonti LR, Dias S, Leitão CB, Kramer CK, Klassman LP, Welton NJ, Ades AE, Gross JL.

J Diabetes Complications. 2016 Aug;30(6):1192-200. doi: 10.1016/j.jdiacomp.2016.04.020. Epub 2016 Apr 29.

PMID:
27217022
26.

The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis.

Price MJ, Ades AE, Soldan K, Welton NJ, Macleod J, Simms I, DeAngelis D, Turner KM, Horner PJ.

Health Technol Assess. 2016 Mar;20(22):1-250. doi: 10.3310/hta20220. Review.

27.

The relative responsiveness of test instruments can be estimated using a meta-analytic approach: an illustration with treatments for depression.

Kounali DZ, Button KS, Lewis G, Ades AE.

J Clin Epidemiol. 2016 Sep;77:68-77. doi: 10.1016/j.jclinepi.2016.03.005. Epub 2016 Mar 17.

PMID:
26994662
28.

The Cost Effectiveness of Psychological and Pharmacological Interventions for Social Anxiety Disorder: A Model-Based Economic Analysis.

Mavranezouli I, Mayo-Wilson E, Dias S, Kew K, Clark DM, Ades AE, Pilling S.

PLoS One. 2015 Oct 27;10(10):e0140704. doi: 10.1371/journal.pone.0140704. eCollection 2015.

29.

Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence.

Jones HE, Welton NJ, Ades AE, Pierce M, Davies W, Coleman B, Millar T, Hickman M.

Addiction. 2016 Mar;111(3):438-47. doi: 10.1111/add.13222. Epub 2015 Dec 28. Erratum in: Addiction. 2016 May;111(5):942.

30.

Absolute or relative effects? Arm-based synthesis of trial data.

Dias S, Ades AE.

Res Synth Methods. 2016 Mar;7(1):23-8. doi: 10.1002/jrsm.1184. Epub 2015 Oct 13. No abstract available.

31.

Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis.

van Valkenhoef G, Dias S, Ades AE, Welton NJ.

Res Synth Methods. 2016 Mar;7(1):80-93. doi: 10.1002/jrsm.1167. Epub 2015 Oct 13.

32.

Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis.

Mayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark DM, Ades AE, Pilling S.

Lancet Psychiatry. 2014 Oct;1(5):368-76. doi: 10.1016/S2215-0366(14)70329-3. Epub 2014 Oct 7.

33.

Heightened risk of false positives in a network meta-analysis of social anxiety--Author's reply.

Mayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark DM, Ades AE, Pilling S.

Lancet Psychiatry. 2015 Apr;2(4):293-4. doi: 10.1016/S2215-0366(15)00090-5. Epub 2015 Mar 31. No abstract available.

PMID:
26360072
34.

Minimal clinically important difference on the Beck Depression Inventory--II according to the patient's perspective.

Button KS, Kounali D, Thomas L, Wiles NJ, Peters TJ, Welton NJ, Ades AE, Lewis G.

Psychol Med. 2015 Nov;45(15):3269-79. doi: 10.1017/S0033291715001270. Epub 2015 Jul 13.

35.

Simultaneous synthesis of treatment effects and mapping to a common scale: an alternative to standardisation.

Ades AE, Lu G, Dias S, Mayo-Wilson E, Kounali D.

Res Synth Methods. 2015 Mar;6(1):96-107. doi: 10.1002/jrsm.1130. Epub 2015 Jan 23.

36.

Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment: Choosing among Statins in Primary Prevention.

Tervonen T, Naci H, van Valkenhoef G, Ades AE, Angelis A, Hillege HL, Postmus D.

Med Decis Making. 2015 Oct;35(7):859-71. doi: 10.1177/0272989X15587005. Epub 2015 May 18.

PMID:
25986470
37.

A Bayesian framework to account for uncertainty due to missing binary outcome data in pairwise meta-analysis.

Turner NL, Dias S, Ades AE, Welton NJ.

Stat Med. 2015 May 30;34(12):2062-80. doi: 10.1002/sim.6475. Epub 2015 Mar 24.

38.

Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses.

Welton NJ, Soares MO, Palmer S, Ades AE, Harrison D, Shankar-Hari M, Rowan KM.

Med Decis Making. 2015 Jul;35(5):608-21. doi: 10.1177/0272989X15570113. Epub 2015 Feb 23.

39.

Symptom lead times in lung and colorectal cancers: what are the benefits of symptom-based approaches to early diagnosis?

Biswas M, Ades AE, Hamilton W.

Br J Cancer. 2015 Jan 20;112(2):271-7. doi: 10.1038/bjc.2014.597. Epub 2014 Dec 2.

40.

Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial.

Soares MO, Welton NJ, Harrison DA, Peura P, Shankar-Hari M, Harvey SE, Madan J, Ades AE, Rowan KM, Palmer SJ.

Crit Care. 2014 Dec 1;18(6):649. doi: 10.1186/s13054-014-0649-z.

41.

Extrapolation of Trial-Based Survival Curves Using External Information.

Guyot P, Welton NJ, Beasley M, Ades AE.

Value Health. 2014 Nov;17(7):A326. doi: 10.1016/j.jval.2014.08.587. Epub 2014 Oct 26. No abstract available.

42.
43.

Symptom lead time distribution in lung cancer: natural history and prospects for early diagnosis.

Ades AE, Biswas M, Welton NJ, Hamilton W.

Int J Epidemiol. 2014 Dec;43(6):1865-73. doi: 10.1093/ije/dyu174. Epub 2014 Aug 29.

PMID:
25172138
44.

Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs.

Naci H, van Valkenhoef G, Higgins JP, Fleurence R, Ades AE.

Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):787-92. doi: 10.1161/CIRCOUTCOMES.114.000825. Epub 2014 Aug 5. Review. No abstract available.

PMID:
25097214
45.

Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources.

Jones HE, Hickman M, Welton NJ, De Angelis D, Harris RJ, Ades AE.

Am J Epidemiol. 2014 Jun 1;179(11):1383-93. doi: 10.1093/aje/kwu056. Epub 2014 Apr 11.

46.

Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part B: placing back-calculations in a formal statistical framework.

Jones HE, Hickman M, Kasprzyk-Hordern B, Welton NJ, Baker DR, Ades AE.

Sci Total Environ. 2014 Jul 15;487:642-50. doi: 10.1016/j.scitotenv.2014.02.101. Epub 2014 Mar 15.

47.

Simultaneous multioutcome synthesis and mapping of treatment effects to a common scale.

Lu G, Kounali D, Ades AE.

Value Health. 2014 Mar;17(2):280-7. doi: 10.1016/j.jval.2013.12.006.

48.

Strategies for efficient computation of the expected value of partial perfect information.

Madan J, Ades AE, Price M, Maitland K, Jemutai J, Revill P, Welton NJ.

Med Decis Making. 2014 Apr;34(3):327-42. doi: 10.1177/0272989X13514774. Epub 2014 Jan 21.

49.

Expected value of sample information for multi-arm cluster randomized trials with binary outcomes.

Welton NJ, Madan JJ, Caldwell DM, Peters TJ, Ades AE.

Med Decis Making. 2014 Apr;34(3):352-65. doi: 10.1177/0272989X13501229. Epub 2013 Oct 1.

PMID:
24085289
50.

Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model.

Price MJ, Ades AE, De Angelis D, Welton NJ, Macleod J, Soldan K, Simms I, Turner K, Horner PJ.

Am J Epidemiol. 2013 Aug 1;178(3):484-92. doi: 10.1093/aje/kws583. Epub 2013 Jun 27.

Supplemental Content

Loading ...
Support Center